William M. Ridgway

5.9k total citations · 1 hit paper
96 papers, 4.6k citations indexed

About

William M. Ridgway is a scholar working on Immunology, Genetics and Hepatology. According to data from OpenAlex, William M. Ridgway has authored 96 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 43 papers in Genetics and 42 papers in Hepatology. Recurrent topics in William M. Ridgway's work include Liver Diseases and Immunity (42 papers), Diabetes and associated disorders (32 papers) and Immune Cell Function and Interaction (28 papers). William M. Ridgway is often cited by papers focused on Liver Diseases and Immunity (42 papers), Diabetes and associated disorders (32 papers) and Immune Cell Function and Interaction (28 papers). William M. Ridgway collaborates with scholars based in United States, Japan and China. William M. Ridgway's co-authors include M. Eric Gershwin, Aftab A. Ansari, Patrick S.C. Leung, C. Garrison Fathman, C. Garrison Fathman, Dyana K. Dalton, Cariel Taylor-Edwards, Stefan Brocke, Iris Ferber and Lawrence Steinman and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Nature Immunology.

In The Last Decade

William M. Ridgway

92 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)

1996 777 citations William M. Ridgway et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William M. Ridgway United States	38	2.0k	1.7k	1.4k	983	816	96	4.6k
Maria Serena Longhi United States	41	2.0k 1.0×	2.5k 1.5×	2.3k 1.6×	807 0.8×	478 0.6×	112	5.8k
Minoru Nakamura Japan	36	1.2k 0.6×	1.5k 0.9×	1.5k 1.1×	780 0.8×	376 0.5×	130	3.9k
Sheri M. Krams United States	40	2.1k 1.0×	1.1k 0.6×	1.3k 0.9×	1.1k 1.1×	266 0.3×	148	5.2k
Hermann E. Wasmuth Germany	38	941 0.5×	2.3k 1.3×	2.3k 1.6×	656 0.7×	226 0.3×	81	4.3k
Christothea M. Constandinou United Kingdom	16	1.3k 0.6×	1.6k 1.0×	1.5k 1.1×	664 0.7×	147 0.2×	17	4.1k
Robert A. DeAngelis United States	24	1.8k 0.9×	1.4k 0.8×	1.1k 0.8×	857 0.9×	133 0.2×	37	4.2k
Yves Renaudineau France	41	2.2k 1.1×	304 0.2×	465 0.3×	706 0.7×	602 0.7×	230	5.4k
Elie‐Serge Zafrani France	26	386 0.2×	1.4k 0.8×	1.0k 0.7×	586 0.6×	215 0.3×	55	2.8k
Satoshi Yamagiwa Japan	29	1.5k 0.8×	654 0.4×	576 0.4×	386 0.4×	191 0.2×	106	3.0k
Maria Lorena Abate Italy	31	400 0.2×	3.1k 1.8×	3.2k 2.3×	302 0.3×	287 0.4×	99	4.8k

Countries citing papers authored by William M. Ridgway

Since Specialization

Citations

This map shows the geographic impact of William M. Ridgway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William M. Ridgway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William M. Ridgway more than expected).

Fields of papers citing papers by William M. Ridgway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William M. Ridgway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William M. Ridgway. The network helps show where William M. Ridgway may publish in the future.

Co-authorship network of co-authors of William M. Ridgway

This figure shows the co-authorship network connecting the top 25 collaborators of William M. Ridgway. A scholar is included among the top collaborators of William M. Ridgway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William M. Ridgway. William M. Ridgway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Weici, Patrick S.C. Leung, Koichi Tsuneyama, et al.. (2024). Dietary therapy of murine primary biliary cholangitis induces hepatocellular steatosis: A cautionary tale. Liver International. 44(10). 2834–2846. 2 indexed citations

Rojas, Manuel, et al.. (2023). Molecular mimicry and autoimmunity in the time of COVID-19. Journal of Autoimmunity. 139. 103070–103070. 37 indexed citations

Adams, David E., Luke S. Heuer, Manuel Rojas, Weici Zhang, & William M. Ridgway. (2022). Mutated Pkhd1 alone is sufficient to cause autoimmune biliary disease on the nonobese diabetic (NOD) genetic background. Immunogenetics. 75(1). 27–37. 4 indexed citations

Leung, Patrick S.C., Weici Zhang, Koichi Tsuneyama, et al.. (2022). Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression. Cellular and Molecular Immunology. 19(10). 1130–1140. 25 indexed citations

Li, Meng, et al.. (2021). Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic Peptides. The Journal of Immunology. 207(8). 2051–2059. 5 indexed citations

Chen, Zhilei, Weici Zhang, Carlo Selmi, et al.. (2021). The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function. Autoimmunity Reviews. 20(11). 102942–102942. 36 indexed citations

Irie, Junichiro, M. Kato, Kumiko Tanaka, et al.. (2017). GLP-1 receptor agonist, liraglutide, ameliorates hepatosteatosis induced by anti-CD3 antibody in female mice. Journal of Diabetes and its Complications. 31(9). 1370–1375. 8 indexed citations

Adams, David E., Yuehong Wu, Robert S. Mittler, et al.. (2013). Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice. Journal of Autoimmunity. 47. 94–103. 31 indexed citations

Kawata, Kazuhito, Guoxiang Yang, Yukio Ando, et al.. (2013). Clonality, Activated Antigen-Specific Cd8+ T Cells, And Development of Autoimmune Cholangitis in DntgfβRii Mice. Hepatology. 58(3). 1094–1104. 37 indexed citations

10.

Ueno, Yoshiyuki, Yoko M. Ambrosini, Yuki Moritoki, William M. Ridgway, & M. Eric Gershwin. (2010). Murine models of autoimmune cholangitis. Current Opinion in Gastroenterology. 26(3). 274–279. 30 indexed citations

11.

Zhang, Weici, Masanobu Tsuda, Guoxiang Yang, et al.. (2010). Deletion of Interleukin-6 in Mice With the Dominant Negative Form of Transforming Growth Factor β Receptor II Improves Colitis but Exacerbates Autoimmune Cholangitis. Hepatology. 52(1). 215–222. 25 indexed citations

12.

Ridgway, William M., Laurence B. Peterson, John A. Todd, et al.. (2008). Chapter 6 Gene–Gene Interactions in the NOD Mouse Model of Type 1 Diabetes. Advances in immunology. 100. 151–175. 56 indexed citations

13.

Wakabayashi, Kanji, Zhe‐Xiong Lian, Patrick S.C. Leung, et al.. (2008). Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease†. Hepatology. 48(2). 531–540. 143 indexed citations

14.

Irie, Junichiro, Yuehong Wu, Linda S. Wicker, et al.. (2006). NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. The Journal of Experimental Medicine. 203(5). 1209–1219. 141 indexed citations

15.

Ridgway, William M.. (2006). Dissecting Genetic Control of Autoimmunity in NOD Congenic Mice. Immunologic Research. 36(1-3). 189–196. 12 indexed citations

16.

Koarada, Syuichi, et al.. (2002). Increased Nonobese Diabetic Th1:Th2 (IFN-γ:IL-4) Ratio Is CD4+ T Cell Intrinsic and Independent of APC Genetic Background. The Journal of Immunology. 169(11). 6580–6587. 40 indexed citations

17.

Koarada, Syuichi, Yuehong Wu, & William M. Ridgway. (2001). Increased Entry into the IFN-γ Effector Pathway by CD4+ T Cells Selected by I-Ag7 on a Nonobese Diabetic Versus C57BL/6 Genetic Background. The Journal of Immunology. 167(3). 1693–1702. 31 indexed citations

18.

Ridgway, William M. & C. Garrison Fathman. (1999). MHC structure and autoimmune T cell repertoire development. Current Opinion in Immunology. 11(6). 638–642. 37 indexed citations

19.

Ridgway, William M. & C. Garrison Fathman. (1998). The Association of MHC with Autoimmune Diseases: Understanding the Pathogenesis of Autoimmune Diabetes. Clinical Immunology and Immunopathology. 86(1). 3–10. 29 indexed citations

20.

Ridgway, William M., Marcella Fassò, Amy Lanctot, Colin Garvey, & C. Garrison Fathman. (1996). Breaking self-tolerance in nonobese diabetic mice.. The Journal of Experimental Medicine. 183(4). 1657–1662. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact